| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $6.63 | $6.58 | $6.63 | $4.79 | $4.01 | $2.63 | $3.13 | $3.27 |
| EPS (Diluted) | $6.62 | $6.57 | $6.62 | $4.78 | $4.00 | $2.62 | $3.12 | $3.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.6B | $15.7B | $15.1B | $15.5B | $16.0B | $14.0B | $12.1B | $11.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.5B | $0.4B | $0.7B | $2.1B | $3.2B | $2.0B | $0.3B | $0.3B |
| Total Liabilities | $13.3B | $12.9B | $12.6B | $13.5B | $13.7B | $11.9B | $10.0B | $9.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.3B | $2.8B | $2.4B | $2.0B | $2.3B | $2.2B | $2.1B | $1.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.5B | $0.5B | $0.4B | $0.3B | $0.3B | $0.3B | $0.2B |
| Investing Cash Flow | $-0.6B | $-1.0B | $-1.1B | $-1.0B | $-0.9B | $-0.3B | $-0.3B | $0.4B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.3B | $0.2B | $-0.8B | $-0.5B | $1.8B | $1.8B | $-0.1B | $-0.6B |